This company recently went public with an IPO on Tuesday, August 26th 2025. They issued 2,000,000 shares at $4.00 - $6.00 per share. We will continue to update data for CURX as it becomes available. Curanex Pharmaceuticals (CURX) SEC Filings & 10K Form $5.60 +0.41 (+7.90%) As of 04:00 PM Eastern Add Compare Share Share SEC Filings Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock Recent Curanex Pharmaceuticals SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel DateFilerForm TypeView08/27/20254:05 PMCuranex Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/26/20254:28 PMCuranex Pharmaceuticals (Filer)Form 424B408/26/20254:27 PMCuranex Pharmaceuticals (Filer)Form 424B408/26/20256:30 AMCuranex Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/25/20251:40 PMCuranex Pharmaceuticals (Filer)Form CERT08/25/20259:38 AMCuranex Pharmaceuticals (Filer)Form 8-A12B08/12/202511:15 PMCuranex Pharmaceuticals (Filer)Form EFFECT07/18/20253:59 PMCuranex Pharmaceuticals (Filer)Form S-1/A07/10/20252:52 PMCuranex Pharmaceuticals (Subject)Form FWP07/01/20253:43 PMCuranex Pharmaceuticals (Filer)Form S-1/A03/19/20253:38 PMCuranex Pharmaceuticals (Subject)Form FWP03/17/202511:13 AMCuranex Pharmaceuticals (Filer)Form S-1/A02/14/202510:32 AMCuranex Pharmaceuticals (Filer)Form S-1/A11/27/20244:31 PMCuranex Pharmaceuticals (Filer)Form S-1/A11/01/20244:29 PMCuranex Pharmaceuticals (Filer)Form S-1/A10/16/20244:29 PMCuranex Pharmaceuticals (Filer)Form S-1Registration statement under Securities Act of 1933 (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies 180 Life Sciences 10K Form 4D pharma 10K Form Aesther Healthcare Acquisition 10K Form Ainos 10K Form Alvotech 10K Form ARAVIVE 10K Form Atlantic Coastal Acquisition Corp. II 10K Form Biofrontera 10K Form biote 10K Form BriaCell Therapeutics 10K Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:CURX) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Curanex Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Curanex Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access